Clinical impact of influenza immunization in patients with liver cirrhosis

Joon-Young Song, Hee-Jin Cheong, Seok Hoon Ha, In Sook Hwang, Sae Yoon Kee, Hye Won Jeong, Chang Gyu Lee, Woo Joo Kim

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Influenza vaccine is considered to reduce influenza-related morbidity and mortality in patients with underlying chronic medical conditions. Yet in liver cirrhosis, influenza vaccines have received little attention in determining the potential benefits. Objectives: We intended to evaluate the clinical benefits of influenza vaccination and clinical outcomes of influenza in patients with liver cirrhosis. Methods: We performed a controlled, prospective clinical trial of 311 cirrhotic patients, who were enrolled in October 2004. Among them, 198 patients were vaccinated with a trivalent influenza vaccine and the rest were not vaccinated. Both groups were followed with respect to the occurrence of influenza-like illness (ILI) until May 2005. Results: Overall incidences of ILI (p = 0.064) and culture positivity of influenza (p = 0.009) were remarkably higher in unvaccinated group compared to the vaccinated group. Most of the cirrhotic patients with influenza had fever (91.6%) and complained of myalgia (83.3%) without respiratory symptoms, which were not typical clinical presentations of influenza. Influenza vaccination also decreased influenza-related complication rates in patients with liver cirrhosis. Conclusion: Influenza vaccination should be recommended to all cirrhotic patients. High suspicion is required for early diagnosis and antiviral treatment, allowing for the frequent hepatic decompensation among cirrhotic patients.

Original languageEnglish
Pages (from-to)159-163
Number of pages5
JournalJournal of Clinical Virology
Volume39
Issue number3
DOIs
Publication statusPublished - 2007 Jul 1

Fingerprint

Liver Cirrhosis
Human Influenza
Immunization
Influenza Vaccines
Vaccination
Myalgia
Controlled Clinical Trials
Antiviral Agents
Early Diagnosis
Fever
Morbidity
Mortality
Liver
Incidence

Keywords

  • Influenza
  • Liver Cirrhosis
  • Vaccine

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology

Cite this

Clinical impact of influenza immunization in patients with liver cirrhosis. / Song, Joon-Young; Cheong, Hee-Jin; Ha, Seok Hoon; Hwang, In Sook; Kee, Sae Yoon; Jeong, Hye Won; Lee, Chang Gyu; Kim, Woo Joo.

In: Journal of Clinical Virology, Vol. 39, No. 3, 01.07.2007, p. 159-163.

Research output: Contribution to journalArticle

Song, Joon-Young ; Cheong, Hee-Jin ; Ha, Seok Hoon ; Hwang, In Sook ; Kee, Sae Yoon ; Jeong, Hye Won ; Lee, Chang Gyu ; Kim, Woo Joo. / Clinical impact of influenza immunization in patients with liver cirrhosis. In: Journal of Clinical Virology. 2007 ; Vol. 39, No. 3. pp. 159-163.
@article{4b8ba8a6617846139e4933eb86bba7ef,
title = "Clinical impact of influenza immunization in patients with liver cirrhosis",
abstract = "Background: Influenza vaccine is considered to reduce influenza-related morbidity and mortality in patients with underlying chronic medical conditions. Yet in liver cirrhosis, influenza vaccines have received little attention in determining the potential benefits. Objectives: We intended to evaluate the clinical benefits of influenza vaccination and clinical outcomes of influenza in patients with liver cirrhosis. Methods: We performed a controlled, prospective clinical trial of 311 cirrhotic patients, who were enrolled in October 2004. Among them, 198 patients were vaccinated with a trivalent influenza vaccine and the rest were not vaccinated. Both groups were followed with respect to the occurrence of influenza-like illness (ILI) until May 2005. Results: Overall incidences of ILI (p = 0.064) and culture positivity of influenza (p = 0.009) were remarkably higher in unvaccinated group compared to the vaccinated group. Most of the cirrhotic patients with influenza had fever (91.6{\%}) and complained of myalgia (83.3{\%}) without respiratory symptoms, which were not typical clinical presentations of influenza. Influenza vaccination also decreased influenza-related complication rates in patients with liver cirrhosis. Conclusion: Influenza vaccination should be recommended to all cirrhotic patients. High suspicion is required for early diagnosis and antiviral treatment, allowing for the frequent hepatic decompensation among cirrhotic patients.",
keywords = "Influenza, Liver Cirrhosis, Vaccine",
author = "Joon-Young Song and Hee-Jin Cheong and Ha, {Seok Hoon} and Hwang, {In Sook} and Kee, {Sae Yoon} and Jeong, {Hye Won} and Lee, {Chang Gyu} and Kim, {Woo Joo}",
year = "2007",
month = "7",
day = "1",
doi = "10.1016/j.jcv.2007.04.018",
language = "English",
volume = "39",
pages = "159--163",
journal = "Journal of Clinical Virology",
issn = "1386-6532",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Clinical impact of influenza immunization in patients with liver cirrhosis

AU - Song, Joon-Young

AU - Cheong, Hee-Jin

AU - Ha, Seok Hoon

AU - Hwang, In Sook

AU - Kee, Sae Yoon

AU - Jeong, Hye Won

AU - Lee, Chang Gyu

AU - Kim, Woo Joo

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Background: Influenza vaccine is considered to reduce influenza-related morbidity and mortality in patients with underlying chronic medical conditions. Yet in liver cirrhosis, influenza vaccines have received little attention in determining the potential benefits. Objectives: We intended to evaluate the clinical benefits of influenza vaccination and clinical outcomes of influenza in patients with liver cirrhosis. Methods: We performed a controlled, prospective clinical trial of 311 cirrhotic patients, who were enrolled in October 2004. Among them, 198 patients were vaccinated with a trivalent influenza vaccine and the rest were not vaccinated. Both groups were followed with respect to the occurrence of influenza-like illness (ILI) until May 2005. Results: Overall incidences of ILI (p = 0.064) and culture positivity of influenza (p = 0.009) were remarkably higher in unvaccinated group compared to the vaccinated group. Most of the cirrhotic patients with influenza had fever (91.6%) and complained of myalgia (83.3%) without respiratory symptoms, which were not typical clinical presentations of influenza. Influenza vaccination also decreased influenza-related complication rates in patients with liver cirrhosis. Conclusion: Influenza vaccination should be recommended to all cirrhotic patients. High suspicion is required for early diagnosis and antiviral treatment, allowing for the frequent hepatic decompensation among cirrhotic patients.

AB - Background: Influenza vaccine is considered to reduce influenza-related morbidity and mortality in patients with underlying chronic medical conditions. Yet in liver cirrhosis, influenza vaccines have received little attention in determining the potential benefits. Objectives: We intended to evaluate the clinical benefits of influenza vaccination and clinical outcomes of influenza in patients with liver cirrhosis. Methods: We performed a controlled, prospective clinical trial of 311 cirrhotic patients, who were enrolled in October 2004. Among them, 198 patients were vaccinated with a trivalent influenza vaccine and the rest were not vaccinated. Both groups were followed with respect to the occurrence of influenza-like illness (ILI) until May 2005. Results: Overall incidences of ILI (p = 0.064) and culture positivity of influenza (p = 0.009) were remarkably higher in unvaccinated group compared to the vaccinated group. Most of the cirrhotic patients with influenza had fever (91.6%) and complained of myalgia (83.3%) without respiratory symptoms, which were not typical clinical presentations of influenza. Influenza vaccination also decreased influenza-related complication rates in patients with liver cirrhosis. Conclusion: Influenza vaccination should be recommended to all cirrhotic patients. High suspicion is required for early diagnosis and antiviral treatment, allowing for the frequent hepatic decompensation among cirrhotic patients.

KW - Influenza

KW - Liver Cirrhosis

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=34250215227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250215227&partnerID=8YFLogxK

U2 - 10.1016/j.jcv.2007.04.018

DO - 10.1016/j.jcv.2007.04.018

M3 - Article

VL - 39

SP - 159

EP - 163

JO - Journal of Clinical Virology

JF - Journal of Clinical Virology

SN - 1386-6532

IS - 3

ER -